(Q34520835)

2 August 2017

title

Pharmacokinetic and pharmacodynamic assessments of HMG-CoA reductase inhibitors when coadministered with everolimus (English)

1 reference

2 August 2017

1 reference

1 reference

John M Kovarik

1

1 reference

2 August 2017

Stefan Hartmann

2

1 reference

2 August 2017

Martine Hubert

3

1 reference

2 August 2017

Stephane Berthier

4

1 reference

2 August 2017

Werner Schneider

5

1 reference

2 August 2017

Bernd Rosenkranz

6

1 reference

2 August 2017

Christiane Rordorf

7

1 reference

2 August 2017

publication date

1 February 2002

1 reference

The Journal of Clinical Pharmacology

2 August 2017

published in

1 reference

2 August 2017

volume

42

1 reference

2 August 2017

issue

2

1 reference

2 August 2017

page(s)

222-228

1 reference

Hyperlipidemia in solid organ transplantation.

2 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1177%2F00912700222011148

Approaches to the treatment of hyperlipidemia in the solid organ transplant recipient

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00912700222011148

Clinically significant drug interactions with cyclosporin. An update

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00912700222011148

RAD in de novo renal transplantation: comparison of three doses on the incidence and severity of acute rejection

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00912700222011148

A worldwide, phase III, randomized, controlled, safety and efficacy study of a sirolimus/cyclosporine regimen for prevention of acute rejection in recipients of primary mismatched renal allografts

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00912700222011148

Pharmacokinetic-pharmacodynamic consequences and clinical relevance of cytochrome P450 3A4 inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00912700222011148

Longitudinal assessment of everolimus in de novo renal transplant recipients over the first post-transplant year: pharmacokinetics, exposure-response relationships, and influence on cyclosporine

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00912700222011148

Efficacy of sirolimus compared with azathioprine for reduction of acute renal allograft rejection: a randomised multicentre study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00912700222011148

Rhabdomyolysis in patients receiving lovastatin after cardiac transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00912700222011148

Rhabdomyolysis associated with concomitant use of atorvastatin and cyclosporine

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00912700222011148

Drug-interaction-induced rhabdomyolysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00912700222011148

Development and validation of a high-performance liquid chromatography tandem mass spectrometry assay for atorvastatin, ortho-hydroxy atorvastatin, and para-hydroxy atorvastatin in human, dog, and rat plasma

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00912700222011148

10.1177/00912700222011148

21 January 2018

Identifiers

DOI

1 reference

2 August 2017

1 reference